ArticleInternational journal of dermatology2026

The Risk of Immune-Mediated Skin Disease Under Dipeptidyl-Peptidase IV Inhibitor: A Global Population-Based Study.

Noor Mruwat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.